Results for tag: "C5a Receptor Antagonist"

The C5a Receptor Antagonist market is a subset of the Immune Disorders Drugs market. C5a Receptor Antagonists are drugs that block the C5a receptor, a protein found on the surface of certain cells in the immune system. By blocking the receptor, these drugs can reduce inflammation and help treat a variety of immune disorders. C5a Receptor Antagonists are used to treat conditions such as rheumatoid arthritis, psoriasis, and lupus. They are also used to treat certain types of kidney disease and to prevent organ rejection in transplant patients. Several companies are involved in the C5a Receptor Antagonist market. These include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more